Prostate cancer Board decisions

The Board has determined that none of the Veteran's service-connected disabilities caused or contributed to his death from positional asphyxia due to a car accident.

The Board has granted service connection for the residuals of a left inguinal hernia and degenerative disease of the cervical spine, but denied service connection for prostate cancer.

The Board has remanded the claims for service connection for type 2 diabetes mellitus, residuals of a stroke, prostate cancer, and an acquired psychiatric disorder (including PTSD) due to new evidence received after the October 2010 supplemental statement of the case.

The Veteran's prostate cancer is found to have had its onset in service and the claim for service connection is granted.

The Veteran's prostate cancer is related to his service in Vietnam and the exposure to Agent Orange, leading to a grant of service connection.

The Veteran's appeal was denied for higher initial disability ratings for prostate cancer and erectile dysfunction, as well as a TDIU. The RO found that the service-connected conditions did not meet the criteria for higher ratings or a TDIU.

The Veteran's prostate cancer is presumed to be related to his service in Vietnam due to herbicide exposure, and the Board has granted service connection for this condition.

The Veteran's urinary incontinence does not meet the criteria for a higher rating, as it does not require absorbent materials or result in daytime voiding between every one to two hours or awakening to void three to four times per night.

The Board has determined that the Veteran does not have a current skin disorder or hypercholesterolemia for which service connection can be granted. The VA examiner found no link between the Veteran's skin condition and his military service, including exposure to contaminated water at Camp Lejeune.

The Board found that the Veteran's residuals of melanoma are not related to his conceded herbicide exposure in service, and denied his claim for service connection. The Veteran is seeking a higher rating for his prostate cancer.

The Veteran is seeking service connection for prostate cancer, which he claims was due to exposure to herbicides during his military service. The case has been remanded for further development regarding the claimed herbicide exposure.

The Veteran's prostate cancer residuals are currently rated at 20 percent, which is the maximum schedular rating available for this condition. The Board finds that his symptoms do not warrant a higher evaluation.

The Veteran's service-connected disabilities, including PTSD, prostate cancer, and degenerative disc disease of the lumbosacral spine, have rendered him unable to secure or maintain substantially gainful employment since September 27, 2007.

The Veteran's prostate cancer residuals have been rated at 40 percent from February 6, 2012 through June 25, 2012 and at 60 percent since June 26, 2012. The appeal is granted for a higher rating.

The Board has determined that the Veteran's claimed conditions are not related to his military service and have denied all of his claims.

The Veteran's prostate cancer was not incurred or aggravated in service and may not be presumed to have been incurred therein.

The Veteran's claims for service connection for prostate cancer and erectile dysfunction are being remanded due to the need for additional development, including verification of herbicide exposure during service.

The Veteran's appeal is being remanded to obtain additional medical records and clarify his claims. The issues are whether he should receive an initial compensable rating for prostate cancer residuals and if erectile dysfunction is service-connected as secondary to prostate cancer.

The Veteran's service-connected prostate cancer and related incontinence residuals have effectively resulted in loss of both lower extremities such as to preclude locomotion without the aid of braces, crutches, canes, or a wheelchair. As such, he is entitled to specially adapted housing.

The Veteran's appeal is being remanded for further development, including a new VA examination to assess the severity of his service-connected prostate cancer residuals and radiation proctitis.